LAG3 Marks Activated but Hyporesponsive NK Cells

IF 3.7 3区 医学 Q2 IMMUNOLOGY
Valeria Vasilyeva, Olivia Makinson, Cynthia Chan, Maria Park, Colin O'Dwyer, Ayad Ali, Abrar Ul Haq Khan, Christiano Tanese de Souza, Mohamed S. Hasim, Sara Asif, Reem Kurdieh, John Abou-Hamad, Edward Yakubovich, Jonathan Hodgins, Paul Al Haddad, Giuseppe Pietropaolo, Julija Mazej, Hobin Seo, Qiutong Huang, Sarah Nersesian, Damien Chay, Nicolas Jacquelot, David Cook, Seung-Hwan Lee, Giuseppe Sciumè, Stephen Waggoner, Michele Ardolino, Marie Marotel
{"title":"LAG3 Marks Activated but Hyporesponsive NK Cells","authors":"Valeria Vasilyeva,&nbsp;Olivia Makinson,&nbsp;Cynthia Chan,&nbsp;Maria Park,&nbsp;Colin O'Dwyer,&nbsp;Ayad Ali,&nbsp;Abrar Ul Haq Khan,&nbsp;Christiano Tanese de Souza,&nbsp;Mohamed S. Hasim,&nbsp;Sara Asif,&nbsp;Reem Kurdieh,&nbsp;John Abou-Hamad,&nbsp;Edward Yakubovich,&nbsp;Jonathan Hodgins,&nbsp;Paul Al Haddad,&nbsp;Giuseppe Pietropaolo,&nbsp;Julija Mazej,&nbsp;Hobin Seo,&nbsp;Qiutong Huang,&nbsp;Sarah Nersesian,&nbsp;Damien Chay,&nbsp;Nicolas Jacquelot,&nbsp;David Cook,&nbsp;Seung-Hwan Lee,&nbsp;Giuseppe Sciumè,&nbsp;Stephen Waggoner,&nbsp;Michele Ardolino,&nbsp;Marie Marotel","doi":"10.1002/eji.70009","DOIUrl":null,"url":null,"abstract":"<p>NK cells are critical for immunosurveillance, yet become dysfunctional when chronically stimulated by virally infected or cancerous cells. This phenomenon is similar to T cell exhaustion but less characterized, limiting therapeutic interventions. As shown for T cells, NK cells often display an increased expression of immune checkpoint proteins (ICP) following chronic stimulation, and ICP blockade therapies are currently being explored for several cancer types, with remarkable patient benefits. Nevertheless, the nature of ICP expression in NK cells is still poorly documented. In this study, we aimed to identify the conditions that lead to and the phenotype of immune checkpoint LAG3-expressing NK cells. Using various experimental models, we found that LAG3 is expressed by murine NK cells upon activation in different contexts, including in response to cancer and acute viral infections. LAG3 marks a subset of immature, proliferating, and activated cells, which, despite activation, have a reduced capacity to respond to a broad range of stimuli. Further characterization also revealed that LAG3+ NK cells exhibit a transcriptional signature similar to that of exhausted CD8+ T cells. Taken together, our results support the use of LAG3 as a marker of dysfunctional NK cells across diverse chronic and acute inflammatory conditions.</p>","PeriodicalId":165,"journal":{"name":"European Journal of Immunology","volume":"55 7","pages":""},"PeriodicalIF":3.7000,"publicationDate":"2025-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/eji.70009","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Immunology","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/eji.70009","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

NK cells are critical for immunosurveillance, yet become dysfunctional when chronically stimulated by virally infected or cancerous cells. This phenomenon is similar to T cell exhaustion but less characterized, limiting therapeutic interventions. As shown for T cells, NK cells often display an increased expression of immune checkpoint proteins (ICP) following chronic stimulation, and ICP blockade therapies are currently being explored for several cancer types, with remarkable patient benefits. Nevertheless, the nature of ICP expression in NK cells is still poorly documented. In this study, we aimed to identify the conditions that lead to and the phenotype of immune checkpoint LAG3-expressing NK cells. Using various experimental models, we found that LAG3 is expressed by murine NK cells upon activation in different contexts, including in response to cancer and acute viral infections. LAG3 marks a subset of immature, proliferating, and activated cells, which, despite activation, have a reduced capacity to respond to a broad range of stimuli. Further characterization also revealed that LAG3+ NK cells exhibit a transcriptional signature similar to that of exhausted CD8+ T cells. Taken together, our results support the use of LAG3 as a marker of dysfunctional NK cells across diverse chronic and acute inflammatory conditions.

Abstract Image

LAG3标记活化但反应低下的NK细胞
NK细胞对免疫监视至关重要,但当受到病毒感染细胞或癌细胞的长期刺激时,它们会变得功能失调。这种现象与T细胞衰竭相似,但特征较少,限制了治疗干预。正如T细胞所示,NK细胞在慢性刺激后经常表现出免疫检查点蛋白(ICP)的表达增加,目前正在探索几种癌症类型的ICP阻断疗法,并对患者有显着的益处。然而,NK细胞中ICP表达的性质仍然缺乏文献记载。在这项研究中,我们旨在确定导致免疫检查点lag3表达NK细胞的条件和表型。通过不同的实验模型,我们发现LAG3在不同的环境下被激活后由小鼠NK细胞表达,包括对癌症和急性病毒感染的反应。LAG3标志着未成熟、增殖和激活细胞的一个子集,尽管被激活,但对广泛刺激的反应能力降低。进一步的表征还表明,LAG3+ NK细胞表现出与耗尽的CD8+ T细胞相似的转录特征。综上所述,我们的研究结果支持使用LAG3作为各种慢性和急性炎症条件下功能失调NK细胞的标记物。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
8.30
自引率
3.70%
发文量
224
审稿时长
2 months
期刊介绍: The European Journal of Immunology (EJI) is an official journal of EFIS. Established in 1971, EJI continues to serve the needs of the global immunology community covering basic, translational and clinical research, ranging from adaptive and innate immunity through to vaccines and immunotherapy, cancer, autoimmunity, allergy and more. Mechanistic insights and thought-provoking immunological findings are of interest, as are studies using the latest omics technologies. We offer fast track review for competitive situations, including recently scooped papers, format free submission, transparent and fair peer review and more as detailed in our policies.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信